Neuroscientists Are Mining Nucleic Acids, Fluids, And Brain Images For Biomarkers Of Risk Of Brain Disorders. This Book Brings Clarity To Several Debates On The Neuroethics Of Biomarkers By Arguing For The Abandonment Of A Categorical Concept Of Disorder (sick Vs. Well) And The Adoption Of An Explicitly Probabilistic One. The Biomedical Promise Of Biomarkers -- Bioprediction Of Brain Disorder : Definitions And Scope -- There Is More Light Here : Re-illuminating The Categories Of Mental -- The Probability Dysfunction -- The Practical Ethics Of Predictive Markers In Diagnosis : Can Risk Banding Address The Ethical Controversy Surrounding Psychosis Risk Syndrome And Preclinical Alzheimer's Disease? -- Enhanced Responsibility : Foreseeability And New Obligations To Others -- Reduced Responsibility : Distinguishing Conditions In Which Biomarkers Properly Reduce Legal Responsibility -- Bioprediction And Priority -- Conclusion By Matthew L. Baum. Includes Bibliographical References And Index.